Featured Entrepreneurs

Since 2010, MassChallenge has accelerated more than 1,500 startups that have raised more than $3 billion in funding, generated more than $2 billion in revenue, and created more than 80,000 total jobs. 

Our startups

Be inspired. Search our startups.

Clear  
HaYa Therapeutics
HaYa Therapeutics

Heart failure as a consequence of myocardial fibrosis is the world’s biggest killer and represents a significant unmet medical need. No therapies currently exist that either directly target the heart or the fibrotic process itself. We have discovered a heart specific regulator of fibrosis – the long noncoding RNA, Wisper. By using our first-in-class proprietary approach to target Wisper, we are able to block myocardial fibrosis and treat heart failure in pre-clinical animal models.
We are developing a first-in-class biopharmaceutical therapy to treat heart failure.

Connect with HaYa Therapeutics

2017

2017 Switzerland Gold Winner

Sub industry

Therapeutics (Pharma / Biotech)

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.